Patients with milder severities of HFRS typically mount vigorous HTNV-specific CD4+ and CD8+ T-cell responses directed against the epitopes of HTNV, whereas patients with severe or critical HFRS tend to have weak and narrowly focused T-cell responses (20–22). This evidence concerns the gene CD4 and hemorrhagic fever with renal syndrome.